BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17050670)

  • 1. A novel mechanism for p53 to regulate its target gene ECK in signaling apoptosis.
    Jin YJ; Wang J; Qiao C; Hei TK; Brandt-Rauf PW; Yin Y
    Mol Cancer Res; 2006 Oct; 4(10):769-78. PubMed ID: 17050670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression.
    Yin Y; Liu YX; Jin YJ; Hall EJ; Barrett JC
    Nature; 2003 Apr; 422(6931):527-31. PubMed ID: 12673251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DUSP1 is controlled by p53 during the cellular response to oxidative stress.
    Liu YX; Wang J; Guo J; Wu J; Lieberman HB; Yin Y
    Mol Cancer Res; 2008 Apr; 6(4):624-33. PubMed ID: 18403641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
    Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
    Huang Y; Tan M; Gosink M; Wang KK; Sun Y
    Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage.
    Jin S; Fan F; Fan W; Zhao H; Tong T; Blanck P; Alomo I; Rajasekaran B; Zhan Q
    Oncogene; 2001 May; 20(21):2683-90. PubMed ID: 11420680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 binds to a novel recognition sequence in the proximal promoter of the rat muscle creatine kinase gene and activates its transcription.
    Zhao J; Schmieg FI; Logsdon N; Freedman D; Simmons DT; Molloy GR
    Oncogene; 1996 Jul; 13(2):293-302. PubMed ID: 8710368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.
    Mirza A; Wu Q; Wang L; McClanahan T; Bishop WR; Gheyas F; Ding W; Hutchins B; Hockenberry T; Kirschmeier P; Greene JR; Liu S
    Oncogene; 2003 Jun; 22(23):3645-54. PubMed ID: 12789273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAC1 is a direct transcription target of E2F-1 in apoptotic signaling.
    Wu J; Jin YJ; Calaf GM; Huang WL; Yin Y
    Oncogene; 2007 Oct; 26(45):6526-35. PubMed ID: 17471234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells.
    Yu J; Baron V; Mercola D; Mustelin T; Adamson ED
    Cell Death Differ; 2007 Mar; 14(3):436-46. PubMed ID: 16990849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 short peptide (p53pep164) regulates lipopolysaccharide-induced tumor necrosis factor-alpha factor/cytokine expression.
    Tang X; Molina M; Amar S
    Cancer Res; 2007 Feb; 67(3):1308-16. PubMed ID: 17283168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual specificity phosphatase 1/CL100 is a direct transcriptional target of E2F-1 in the apoptotic response to oxidative stress.
    Wang J; Yin DP; Liu YX; Baer R; Yin Y
    Cancer Res; 2007 Jul; 67(14):6737-44. PubMed ID: 17638884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites.
    Qian H; Wang T; Naumovski L; Lopez CD; Brachmann RK
    Oncogene; 2002 Nov; 21(51):7901-11. PubMed ID: 12420228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes.
    Tanaka T; Ohkubo S; Tatsuno I; Prives C
    Cell; 2007 Aug; 130(4):638-50. PubMed ID: 17719542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genomic map of p53 binding sites identifies novel p53 targets involved in an apoptotic network.
    Miled C; Pontoglio M; Garbay S; Yaniv M; Weitzman JB
    Cancer Res; 2005 Jun; 65(12):5096-104. PubMed ID: 15958553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia induces p53-dependent transactivation and Fas/CD95-dependent apoptosis.
    Liu T; Laurell C; Selivanova G; Lundeberg J; Nilsson P; Wiman KG
    Cell Death Differ; 2007 Mar; 14(3):411-21. PubMed ID: 16917513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter.
    Liu H; Hew HC; Lu ZG; Yamaguchi T; Miki Y; Yoshida K
    Biochem J; 2009 Aug; 422(3):543-51. PubMed ID: 19558368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional control of human p53-regulated genes.
    Riley T; Sontag E; Chen P; Levine A
    Nat Rev Mol Cell Biol; 2008 May; 9(5):402-12. PubMed ID: 18431400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53CSV, a novel p53-inducible gene involved in the p53-dependent cell-survival pathway.
    Park WR; Nakamura Y
    Cancer Res; 2005 Feb; 65(4):1197-206. PubMed ID: 15735003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a DNA element that can enhance p53-mediated transactivation.
    Shiio Y; Yamamoto T; Yamaguchi N
    Oncogene; 1993 Aug; 8(8):2059-65. PubMed ID: 8393159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.